Showing results (41-50 of 118) with videos related to
Sort By:
Pageof 12
European Addiction Research|November 7, 2013
Effect of smoking status on healthcare costs and resource utilization in patients with type 2 diabetes in routine clinical practice: a retrospective nested case-control economic studyAntoni Sicras-Mainar, Javier Rejas-Gutiérrez, Ruth Navarro-Artieda, et al.Expert Review of Pharmacoeconomics & Outcomes Research|December 24, 2021
All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in SpainJavier Rejas, Antoni Sicras-Mainar, Aram Sicras-Navarro, et al.Atencion Primaria|February 24, 2009
[Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings]Antoni Sicras-Mainar, Milagrosa Blanca-Tamayo, Ruth Navarro-Artieda, et al.Journal of Evaluation in Clinical Practice|September 28, 2016
Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivityAntoni Sicras-Mainar, Javier Rejas-Gutiérrez, María Pérez-Páramo, et al.Atencion Primaria|February 2, 2010
[All-cause mortality and incidence of major cardiovascular events in hypertensive patients with ASCOT-type profile in a Spanish population setting]Antoni Sicras-Mainar, Jaime Fernández de Bobadilla, Ruth Navarro-Artieda, et al.Clinicoeconomics and Outcomes Research : CEOR|August 29, 2013
Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort studyAntoni Sicras-Mainar, Silvia Díaz-Cerezo, Verónica Sanz de Burgoa, et al.Plos One|November 5, 2014
Influence of the CYP2D6 isoenzyme in patients treated with venlafaxine for major depressive disorder: clinical and economic consequencesAntoni Sicras-Mainar, Pablo Guijarro, Beatriz Armada, et al.Annals of General Psychiatry|August 7, 2012
Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary careAntoni Sicras-Mainar, Jorge Maurino, Luis Cordero, et al.Atencion Primaria|July 14, 2012
[Costs and associated factors with optimal and suboptimal responses to the treatment of major depressive disorder]Antoni Sicras-Mainar, Jorge Mauriño, Luis Cordero, et al.Revista Espanola De Cardiologia (English Ed.)|December 31, 2020
Epidemiology and treatment of heart failure in Spain: the HF-PATHWAYS studyAntoni Sicras-Mainar, Aram Sicras-Navarro, Beatriz Palacios, et al.Pageof 12